CHANGCHUN, China and LOS ANGELES, July 21 ChinaYongxin Pharmaceuticals Inc. (OTC Bulletin Board: CYXN) ("China Yongxin" orthe "Company"), one of the leading health products distribution and retailsales companies in China, today announced the opening of seven new chaindrugstores in July. These new openings bring the Company's number of storesto 30 in Changchun City, 31 in Baishan City, and a total of 110 throughoutNortheastern China. The Company has expedited the pace of store openings inorder to reach its previously announced goal of opening 29 stores in 2010.The Company's objective is to become one of the top 20 pharmaceutical retailchain enterprises in China.
China Yongxin held grand opening ceremonies in July for all six new storesin Changchun City, which is expected to further increase awareness of theChina Yongxin brand in the community. These six locations were chosen fortheir strategic locations in high density and high income residentialdistricts. The Lin He Street store is located on the beautiful River of Lifethat runs through Changchun City, also known for its heavy foot traffic. TheJian Min Street store is located in the "My Home" district, adjacent to theRoyal Emerald Palace upscale community. The Fei Yue Road store is located inthe core of China FAW Group district, which has a large residential communitywith a high population density. The De Chang Road store is located in theHongqi Street shopping district, adjacent to the Hospital of Jilin Province.The Chang Da Road and Cambridge Park stores are located near the ChangchunUniversity and Jilin University, respectively, allowing the Company to accessthe universities' large student populations and surrounding residents. Theseventh store is located in Baishan City, adding an additional store to theBai Shan Cao An Tang brand.
The new drugstores provide customers with a wide range of over-the-counterChinese traditional and Western medicines, prescription pharmaceuticals,natural health products including herbal and nutritional supplements, healthfoods, personal care products and cosmetics. These stores will also providecustomers that are located within close proximity with free delivery services,which management believes may be a cost-effective method of attracting morecustomers and increasing sales.
According to Mr. Yongxin Liu, Chairman and CEO, "We are pleased toannounce the opening of a total of 13 new stores in 2010, expanding ourfootprint within densely populated and high income districts. We continue tobe confident that we will reach our projected goals for 2010 and become thelargest drugstore chain in Northeastern China," Mr. Yongxin Liu added.
About China Yongxin Pharmaceuticals Inc.
Founded in 1993, China Yongxin Pharmaceuticals is one of the leadingretailers and distributors of over-the-counter Chinese traditional and Westernmedicines, prescription pharmaceuticals, natural health products includingherbal and nutritional supplements, health foods, personal care products,cosmetics and medical equipment in Northeastern China. Its retail operationsbegan in 2004, and in 2005, it gained franchise rights from one of the world'slargest drug chains for China's Jilin Province.
The Company had become one of the fastest growing drug retailers in Chinathrough its retail chain of 110 drug outlets as well as its wholesaledistribution in Northeastern China. For more information about China YongxinPharmaceuticals Inc., please visit http://www.yongxinchina.com .
Forward Looking Statements
This news release contains certain "forward-looking statements."Forward- looking statements are based on current expectations and assumptionsand are inherently subject to risks and uncertainties, some of which cannot bepredicted or quantified, and many of which are beyond the Company's control.The forward-looking statements are also identified through the use of words"believe," enable," "may," "will," "could," "intends," "estimate,""anticipate," "plan," "predict" "probable," "potential," "possible," "should,""continue," "project", "expect" and other words of similar meaning. Actualresults could differ materially from these forward-looking statements as aresult of a number of risk factors detailed in the Company's periodic reportsfiled with the SEC. Given these risks and uncertainties, investors arecautioned not to place undue reliance on such forward-looking statements andno assurances can be given that such statements will be achieved. ChinaYongxin Pharmaceuticals Inc. does not assume any duty to publicly update orrevise the material contained herein.For more information, please contact: CORPORATE China Yongxin Pharmaceuticals Inc. Sam Liu, Chief Operating Officer Tel: +1-626-581-9098 Email: [email protected]
INVESTOR RELATIONS Strategic Growth International, Inc. Richard Cooper, Chairman Tel: +1-212-838-1444 Email: [email protected]
SOURCE China Yongxin Pharmaceuticals Inc.